Clinical Trials Directory

Trials / Completed

CompletedNCT02602483

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Spherium Biomed · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The objetive of this study is to explore the efficacy and safety of a triple combination of ibuprofen, magnesium and ascorbic acid for acute pain treatment in TMJD patients

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen
DRUGMagnesium
DRUGAscorbic Acid
DRUGPlacebo

Timeline

Start date
2015-12-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-11-11
Last updated
2017-01-19

Locations

4 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02602483. Inclusion in this directory is not an endorsement.

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Te (NCT02602483) · Clinical Trials Directory